Invest now
Sanofi Consumer Healthcare India share price
Balanced risk
- ₹4,576.00(0.41%)July 17, 2026 15:29:34 PM IST
- NSE
- BSE
- Vol : 2.25 K (NSE + BSE)Last 20 day avg : 12.33 K
Sanofi Consumer Healthcare India is trading 0.41% upper at Rs 4,576.00 as compared to its last closing price. Sanofi Consumer Healthcare India has been trading in the price range of 4,590.00 & 4,527.00. Sanofi Consumer Healthcare India has given 0.85% in this year & 1.16% in the last 5 days. Sanofi Consumer Healthcare India has TTM P/E ratio 38.38 as compared to the sector P/E of 25.09.There are 1 analysts who have initiated coverage on Sanofi Consumer Healthcare India. There are 1 analysts who have given it a strong buy rating & 0.00 analysts have given it a buy rating. 0.00 analysts have given the stock a sell rating.The company posted a net profit of 67.80 Crores in its last quarter.Listed peers of Sanofi Consumer Healthcare India include Sun Pharmaceutical Industries (-0.87%), Divi's Laboratories (-0.84%), Torrent Pharmaceuticals (-4.72%).The Mutual Fund holding in Sanofi Consumer Healthcare India was at 13.63% in 31 Mar 2026. The MF holding has increased from the last quarter. The FII holding in Sanofi Consumer Healthcare India was at 2.75% in 31 Mar 2026. The FII holding has decreased from the last quarter.
- Overview
- Financials
- Forecast
- Technical Analysis
- Peers
- Shareholding
- About the company
- FAQ
Overview
- 1 D
- 5 D
- 1 M
- 3 M
- 6 M
- 1 Y
- 5 Y
- MAX
Loading...
Key Metrics
Updated on 20 Jul 2026, 03:58 AM IST
- Debt To EquityHigher than industry0.06The debt-to-equity ratio, indicating a company's financial leverage.
- Dividend YieldHigher than industry1.65Annual dividends as a percentage of the stock price.
- P/E-Price-to-earnings ratio based on trailing 12-month earnings
- P/B-The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
- Beta-Beta measures a stock's volatility compared to the overall market. A beta > 1 indicates higher volatility than the market.
- PEG Ratio-The PEG ratio evaluates a stock's valuation by comparing its P/E ratio to its earnings growth rate. A lower PEG suggests better value relative to growth
Price range
Day Range
|
| ||||
52 week range
|
| ||||
Sanofi Consumer Healthcare India News
Sanofi Consumer Healthcare India Peers
Return Comparison
Peers Comparison
Names | Price | %Change | Market Cap | P/E | P/B | Dividend Yield | Debt to Equity |
|---|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries | 1,933.10 | -0.87 | 4,63,804.52 | 38.74 | 5.6 | - | - |
| Divi's Laboratories | 7,258.05 | -0.84 | 1,92,678.42 | 74.01 | 11.59 | - | - |
| Torrent Pharmaceuticals | 4,766.60 | -4.72 | 1,61,373.73 | 76.16 | 20.12 | - | - |
| Cipla | 1,418.40 | -0.77 | 1,14,584.78 | 27.78 | 3.35 | - | - |
| Zydus Lifesciences | 1,142.75 | -0.93 | 1,13,894.32 | 21.38 | 4.28 | - | - |
Mutual Fund Ownership
View allSanofi Consumer Healthcare India Corporate Actions
View all- Board Meetings
- AGM
- Dividends
- Bonus
- Split
- Rights
| Meeting Date | Purpose |
|---|---|
| 2026-04-28 | Quarterly Results |
| 2026-02-25 | Audited Results & Final Dividend |
| 2025-11-12 | Quarterly Results |
| 2025-08-04 | Quarterly Results |
| 2025-05-02 | Quarterly Results |
About the company Sanofi Consumer Healthcare India
- IndustryBiotechnology & Drugs
- ISININE0UOS01011
- BSE Code544250
- NSE CodeSANOFICONR
Sanofi Consumer Healthcare India Limited is an India-based company. It is engaged in the business of manufacturing, producing, processing, marketing, formulating, buying, trading, storing, packing, selling, distributing, importing, exporting, providing consultancy and otherwise dealing in all kinds of varieties of pharmaceuticals, especially consumer healthcare products, including: basic drugs; drug intermediates; chemical, medical, biological and electrolytic drugs, ingredients, Medicare, preparations and compositions; medicines, preparations and formulations in all or any forms, including formulations in which various drugs are processed; patents, medicines, drugs enzymes, fermentations and generic products, vitamin and vitamins products tonic, food products, nutritional products, products in therapies such as pain care, allergy, digestive health, cough & cold, sleep, general wellness and hormones and hormone products, and ingredients of every kind and other articles, and compounds.
Sanofi Consumer Healthcare India Share Price FAQs
Sanofi Consumer Healthcare India is trading at 4576.00 as on Fri Jul 17 2026 09:59:34. This is 0.41% upper as compared to its previous closing price of 4557.40.
The market capitalization of Sanofi Consumer Healthcare India is 10554.46 Cr as on Fri Jul 17 2026 09:59:34.
The average broker rating on Sanofi Consumer Healthcare India is Strong Buy. The breakup of analyst rating is given below -
- 1 analysts have given a strong buy rating
- 0.00 analysts have given a buy rating
- 0.00 analysts have given a hold rating
- 0.00 analysts have given a sell rating
- 0.00 analysts have given a strong sell rating
The 52 wk high for Sanofi Consumer Healthcare India is 5493.10 whereas the 52 wk low is 3950.50
Sanofi Consumer Healthcare India can be analyzed on the following key metrics -
- TTM P/E: 38.38
- Sector P/E: 25.09
- Dividend Yield: 1.65%
- D/E ratio: -
Sanofi Consumer Healthcare India reported a net profit of 240.10 Cr in 2025.
The Mutual Fund Shareholding was 13.63% at the end of 31 Mar 2026.
Quick Links
EQUITY QUICK LINKS
Sanofi Consumer Healthcare India QUICK LINKS
FROM MARKETS
RELATED LINKS
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.